A Flagship VentureLabs Company

Ensemble Therapeutics Corporation

99 Erie Street

Cambridge, MA  02139

Tel: 617.492.6977


Leadership:
John Ripple
CEO


Website:
www.ensembletherapeutics.com


Information:
info@ensembletx.com

Ensemble Therapeutics Corporation

Flagship Partners:  Noubar Afeyan, Doug Cole
Initial Investment: 
2004
Status: 
Private

Ensemble Therapeutics is deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Ensemble is leveraging its macrocycle drug discovery expertise to fuel its proprietary drug candidate pipeline while also pursuing collaborations with pharmaceutical partners. Ensemble has entered high-value partnerships including alliances with Boehringer Ingelheim, Genentech, Bristol-Myers Squibb and Pfizer to access Ensemble’s macrocycle libraries for purposes of affinity screening drug discovery against difficult-to-address targets. 

Noubar Afeyan and Doug Cole are on the Board of Directors.